Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Farhat Nasim

      Articles By : Farhat Nasim

      CDSCO adds another port for enhancing import of drugs

      CDSCO adds another port for enhancing import of drugs

      Farhat Nasim13 Oct 2019 3:37 PM IST
      New Delhi: Through a recent Gazette notification, the apex drug regulatory body Central Drugs Standard Control Organization (CDSCO) has apprised about...
      Regulation of all medical devices: DoP, AiMeD, Biotech Consortium to create comprehensive roadmap

      Regulation of all medical devices: DoP, AiMeD, Biotech Consortium to create comprehensive roadmap

      Farhat Nasim13 Oct 2019 9:40 AM IST
      New Delhi: At a recent conference, jointly organized by Department of Pharmaceuticals (DoP), Association of Indian Medical Device Industry (AiMeD) and...
      Gilead, Galapagos reports efficacy, safety results on rheumatoid arthritis drug Filgotinib

      Gilead, Galapagos reports efficacy, safety results on rheumatoid arthritis drug Filgotinib

      Farhat Nasim13 Oct 2019 9:00 AM IST
      New Delhi: Gilead Sciences, Inc. and Galapagos NV recently announced that Week 52 data from the registrational Phase 3 FINCH 1 and FINCH 3 trials of...
      Punjab: Chemist shot for denying habit-forming drug to patient

      Punjab: Chemist shot for denying habit-forming drug to patient

      Farhat Nasim12 Oct 2019 3:36 PM IST
      The chemist tried to explain to him the restrictions imposed on providing habit-forming drugs sans prescription. However, the miscreants fired at him...
      OxyContin maker Purdue Pharma seeks to halt opioid lawsuits

      OxyContin maker Purdue Pharma seeks to halt opioid lawsuits

      Farhat Nasim12 Oct 2019 9:00 AM IST
      New Delhi: OxyContin maker Purdue Pharma LP will ask a U.S. Bankruptcy Judge on Friday to pause litigation against the company and its owners over the...
      Accused of Swindling lakhs of rupees, Pharma sales representative hangs self

      Accused of Swindling lakhs of rupees, Pharma sales representative hangs self

      Farhat Nasim11 Oct 2019 3:05 PM IST
      The incident triggered everyone and the deceased's kin filed a complaint with the Byatarayanapura police alleging that the pharma firm's manager...
      Sun Pharma ILUMYA phase 3 trial shows significant skin clearance in people with Plaque Psoriasis

      Sun Pharma ILUMYA phase 3 trial shows significant skin clearance in people with Plaque Psoriasis

      Farhat Nasim11 Oct 2019 9:30 AM IST
      New Delhi: Sun Pharmaceutical Industries Ltd. recently announced that one of its wholly-owned subsidiaries presented long-term follow-up data from...
      Bayer inks deals with 11 startups under G4A to develop new digital health solutions

      Bayer inks deals with 11 startups under G4A to develop new digital health solutions

      Farhat Nasim11 Oct 2019 9:25 AM IST
      New Delhi: Bayer announced recently that the company has signed collaboration agreements with eleven digital health startups. As part of the program,...
      Dr Reddys Chairman Satish Reddy named as New President of Indian Pharmaceutical Alliance

      Dr Reddys Chairman Satish Reddy named as New President of Indian Pharmaceutical Alliance

      Farhat Nasim10 Oct 2019 5:01 PM IST
      Dr Reddy's Labs' Chairman, Satish Reddy played a key role in shaping policies concerning the pharmaceutical sector as well as the economy, such as...
      Lupin Mandideep facility gets GMP certificate from Japanese agency PMDA

      Lupin Mandideep facility gets GMP certificate from Japanese agency PMDA

      Farhat Nasim10 Oct 2019 9:45 AM IST
      Pharmaceutical and Medical Devices Agency (PMDA) inspection closed with no critical or major observations. The GMP Certificate issued by the Japanese...
      CDSCO Committee to draft new guidelines for effective recall of substandard drugs

      CDSCO Committee to draft new guidelines for effective recall of substandard drugs

      Farhat Nasim7 Oct 2019 5:29 PM IST
      New Delhi: To examine the issues regarding effective recall system of drugs found Not of Standard Quality (NSQ) and to review the recall guidelines...
      ZENTEL VERSUS FENTEL: HC restrains manufacture, sale of medicine for violation of trademark

      ZENTEL VERSUS FENTEL: HC restrains manufacture, sale of medicine for violation of trademark

      Farhat Nasim6 Oct 2019 11:10 AM IST
      New Delhi: In a relief to the pharmaceutical giant in a trademark matter, the Delhi High Court has recently restrained the manufacture or sale of...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok